Literature DB >> 2967324

T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.

S Hirohata1, D F Jelinek, P E Lipsky.   

Abstract

The capacity of mAb directed at the CD3 molecular complex (64.1) to induce T cell-dependent B cell proliferation and differentiation was examined. Coculture of B cells with mitomycin C-treated T4 cells (T4 mito) stimulated by immobilized 64.1 resulted in marked B cell proliferation and Ig-secreting cells (ISC) generation in the absence of any additional stimulation. The magnitude of the B cell responses induced by immobilized 64.1-stimulated T4 mito was far greater than that induced by other stimuli, such as Staphylococcus aureus plus factors produced by mitogen-activated T cells, PWM, or soluble 64.1. The induction of maximal B cell responsiveness required direct contact between activated T cells and responding B cells. Of note, immobilized 64.1 also induced B cell proliferation and ISC generation in the presence of mitomycin C-treated T8 cells. By contrast, immobilized 64.1 stimulated T4 or T8 cells that had not been treated with mitomycin C induced very modest ISC generation and suppressed B cell responses supported by T4 mito even in the presence of exogenous IL-2 or factors produced by mitogen-activated T cells. The interactions between T and B cells in these cultures not only induced B cell responses, but also enhanced the production of IL-2 by activated T cells. Increased IL-2 production was facilitated when culture conditions afforded the opportunity for contact between B cells and activated T cells. These results indicate that the establishment of interactions between B cells and anti-CD3-stimulated T4 or T8 cells provides all of the signals necessary for proliferation and differentiation of B cells without other stimuli and also augments the production of lymphokines by the activated T cells. The data emphasize the role of Ag-nonspecific interactions between B cells and T cells in promoting polyclonal responses of both cell types.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967324

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Human B lymphocytes mature.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

2.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Delineation of the functional capacity of human neonatal lymphocytes.

Authors:  J B Splawski; D F Jelinek; P E Lipsky
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 4.  The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.

Authors:  L S Marshall; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

5.  Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.

Authors:  N R Ling; B Brown; D Hardie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand.

Authors:  S Hirohata
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

7.  T-cell-derived extracellular vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2.

Authors:  Juan Yang; Guohui Dang; Silin Lü; Huiying Liu; Xiaolong Ma; Lulu Han; Jiacheng Deng; Yutong Miao; Xiaopeng Li; Fangyu Shao; Changtao Jiang; Qingbo Xu; Xian Wang; Juan Feng
Journal:  FASEB J       Date:  2019-08-31       Impact factor: 5.191

8.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

9.  Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.

Authors:  C J Punt; J A Barbuto; H Zhang; W J Grimes; K D Hatch; E M Hersh
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

10.  Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis.

Authors:  J G Hanly; D Pledger
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.